Skip to main content

Research Repository

Advanced Search

Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study

Suehs, Carey M.; Menzies-Gow, Andrew; Price, David; Bleecker, Eugene R.; Canonica, Giorgio Walter; Gurnell, Mark; Bourdin, Arnaud

Authors

Carey M. Suehs

Andrew Menzies-Gow

David Price

Eugene R. Bleecker

Giorgio Walter Canonica

Mark Gurnell

Arnaud Bourdin



Contributors

Abstract

Rationale: There is a need to minimize oral corticosteroid (OCS) use in patients with asthma to prevent their costly and burdensome adverse effects. Current guidelines do not provide recommendations for OCS tapering in patients with asthma.

Objectives: To develop expert consensus on OCS tapering among international experts.

Methods: A modified Delphi method was used to develop expert consensus statements relating to OCS use, tapering, adverse effects, adrenal insufficiency, and patient–physician shared decision-making. Initial statements proposed by experts were categorized, filtered for repetition, and presented back to experts over three ranking rounds to obtain consensus (≥70% agreement).

Measurements and Main Results: One hundred thirty-one international experts participated in the study, and 296 statements were ranked. Numerous recommendations and guidance regarding appropriate OCS use were established. Experts agreed that OCS tapering should be attempted in all patients with asthma receiving maintenance OCS therapy, with personalization of tapering rhythm and speed. The importance of recognizing individual adverse effects was also established; however, a unified approach to the assessment of adrenal insufficiency was not reached. Shared decision-making was considered an important goal during the tapering process.

Conclusions: In this Delphi study, expert consensus statements were generated on OCS use, tapering, adverse-effect screening, and shared decision-making, which may be used to inform clinical practice. Areas of nonconsensus were identified, highlighting uncertainty among the experts around some aspects of OCS use in asthma, such as adrenal insufficiency, which underscores the need for further research in these domains.

Citation

Suehs, C. M., Menzies-Gow, A., Price, D., Bleecker, E. R., Canonica, G. W., Gurnell, M., & Bourdin, A. (2021). Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study. American Journal of Respiratory and Critical Care Medicine, 203(7), 871-881. https://doi.org/10.1164/rccm.202007-2721oc

Journal Article Type Article
Acceptance Date Oct 28, 2020
Online Publication Date Oct 8, 2020
Publication Date Apr 1, 2021
Deposit Date Dec 10, 2021
Publicly Available Date Oct 23, 2024
Journal American Journal of Respiratory and Critical Care Medicine
Print ISSN 1073-449X
Publisher American Thoracic Society
Peer Reviewed Peer Reviewed
Volume 203
Issue 7
Pages 871-881
DOI https://doi.org/10.1164/rccm.202007-2721oc
Keywords Adrenal insufficiency; Adverse effects; Shared decision-making; Biological treatments
Public URL https://hull-repository.worktribe.com/output/3894865
Other Repo URL https://hdl.handle.net/2164/15375

Files

Accepted manuscript (986 Kb)
PDF

Copyright Statement
Originally Published in: Suehs CM, Menzies-Gow A, Price D, Bleecker ER, Canonica GW, Gurnell M, Bourdin A; Oral Corticosteroids Tapering Delphi Expert Panel. Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study. Am J Respir Crit Care Med. 2021 Apr 1;203(7):871-881.
DOI: 10.1164/rccm.202007-2721OC
Copyright © 2020 by the American Thoracic Society
The final publication is available at https://doi.org/10.1164/rccm.202007-2721OC.





You might also like



Downloadable Citations